Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology

Published:2013-08 Issue:4 Volume:13 Page:486-496
ISSN:1471-4892
Container-title:Current Opinion in Pharmacology
language:en
Short-container-title:Current Opinion in Pharmacology

Author:

Workman Paul,Al-Lazikani Bissan,Clarke Paul A

Funder

Cancer Research UK

The Institute of Cancer Research

Cancer Research UK Centre

National Institute of Health Research

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference73 articles.

1. Addressing the growing international challenge of cancer: a multinational perspective;Varmus;Sci Transl Med,2013

2. The new era in cancer research;Varmus;Science,2006

3. Emperor of All Maladies;Mukherjee,2011

4. Exploiting the cancer genome: strategies for the discovery and clinical development of targeted molecular therapeutics;Yap;Annu Rev Pharmacol Toxicol,2012

5. Circumventing cancer drug resistance in the era of personalized medicine;Garraway;Cancer Discov,2012

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G2/M phase arrest via PI3K/AKT signaling pathway;Journal of Ethnopharmacology;2024-01

2. The Interplay of Nutrigenomics and Cancer Research;Interdisciplinary Cancer Research;2024

3. Cancer Precision Drug Discovery Using Big Data and Artificial Intelligence Technologies;Research Anthology on Bioinformatics, Genomics, and Computational Biology;2023-12-29

4. The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation;Cellular & Molecular Immunology;2023-12-07

5. Artificial Intelligence (AI) Game Changer in Cancer Biology;Marvels of Artificial and Computational Intelligence in Life Sciences;2023-09-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3